Regeneron Pharmaceuticals, Inc.
Main Office: 777 Old Saw Mill River Road | Tarrytown | NY | 10591
Phone: 914-347-7000 | Fax: 914-347-2113

Regeneron Pharmaceuticals, Inc.



Our first approved product, ARCALYST® (rilonacept), an anti-inflammatory agent, has been available to patients in the U.S. since 2008. In late 2011, we launched EYLEA® (aflibercept) Injection, also known in the scientific literature as VEGF Trap-Eye and Intravitreal Aflibercept Injection, and received approval from the FDA for a second indication in September 2012. In August 2012, Regeneron and Sanofi, obtained FDA approval for ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion.

Legal Jobs in Tarrytown and Near Locations